Biocare Rx Specialty Pharm LLC entered the industry of in 2005 and has grown to employ 1 to 4 people, generating an annual revenue of $2.500.000 to $4.999.999. The NAICS classifies this business under the code 4461100, which describes it as a . For further clarification, the SIC classifies this business under the code 5912 and described it as a . The business provides service to the B2C market.
To acquire more information, please contact Steven Zeltser, President by calling (818) 382-3500 during business hours. You can also write to the business’ Single Location at 5435 Balboa Boulevard # 210, Encino, California CA 91316. You can also visit the company’s website at biocarerx.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Biocare Rx Specialty Pharm LLC |
Representative: | Steven Zeltser, President |
Place of Business: | 5435 Balboa Boulevard # 210, Encino, CA 91316 |
Contact Number: | (818) 382-3500 |
Website: | biocarerx.com |
Type of Service: | |
SIC Number: | 5912 |
NAICS Number: | 4461100 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Began: | 2005 |
Income/Year: | $2.500.000 to $4.999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Biocare Rx Specialty Pharm LLC is a company operating from Los Angeles, California providing professional and relevant B2C variables. It was founded in 2005 and registered with the SIC code 5912 as , and with the NAICS code 4461100 as .
With a current employee count of 1 to 4, Biocare Rx Specialty Pharm LLC has gone to report making $2.500.000 to $4.999.999 per annum on its journey towards growth. This company invites you to contact its representative Steven Zeltser, President at (818) 382-3500 for related queries, or to locate its Single Location using the coordinates 34.170216,-118.501157.
The Single Location can also be found at the street address 5435 Balboa Boulevard # 210 in Encino, California 91316 and can be engaged online through the company website at biocarerx.com, the company Twitter , and Facebook page .